Suzanne Rivera named new VP for research

Provost W.A. "Bud" Baeslack III announced, on November 4th, the appointment of Suzanne M. Rivera as Case Western Reserve´s new vice president for research, effective this month. Rivera, the university´s associate vice president for research since January 2011, emerged as the top choice after an extensive process involving campuswide nominations of internal university candidates. Since coming to CWRU, Rivera has distinguished herself through a commitment to collaboration and a focus on systems and processes.
Read more about her.


Research Matters

Click here to view previous editions of Research Matters and Research News and Updates.




Latest News

Research Newsletter
December 9, 2014  


Department of Defense

The Department of Defense has announced the following new funding opportunities:

Department of the Army - USAMRAA
DoD PH/TBI Community Partners in Mental Health Research Award

DoD PH/TBI Investigational Treatments for TBI and PTSD Clinical Trial Award

DoD USAMRMC FY15 Broad Agency Announcement for Extramural Medical Research

 
Marquette University

Marquette University, with a generous grant from the Templeton Religion Trust, is pleased to announce a new research initiative on the topics of the self, motivation, and virtue. Approximately ten research proposals at $190,000 each will be funded through this initiative.

The grant competition has four primary aims:
1. To support innovative research on the self, motivation, and virtue.
2. To encourage methodological innovation in the study of the self, motivation, and virtue.
3. To encourage interdisciplinary team work, specifically between social science and humanities.
4. To support scholars new to the investigation of these topics or who have not received funding elsewhere. Research collaborations between younger and more established scholars are especially encouraged.

Research into character and virtue is often conducted by scholars from within a single disciplinary perspective. This disciplinary isolationism is not maximally productive of new knowledge about virtue. To ensure that research funded by this proposal closes the disciplinary gap, successful teams will be comprised of at least one humanist and one scientist who are fully and equally invested in the research project, from its inception to its completion. The aim here is to encourage awardees to think outside of their own disciplinary perspectives, and to broaden their research horizons in ways conducive to creative collaborations and results.

For more information on this extended deadline, please visit the Marquette University website or contact Marquette at: smvproject@marquette.edu.

 
Avoiding Problems with Suspension and Debarment

Federal regulations require Case Western Reserve University to conduct business only with vendors, subcontractors, subawardees and individuals who are in good standing with the federal government. Anyone who is not in good standing with federal agencies cannot work on or provide services for government grants or contracts. People and entities who are subject to these restrictions are generally described as having been "debarred," "suspended" or "excluded."

To avoid inadvertent problems, visit http://www.sam.gov and verify that study staff, collaborators and vendors are not debarred, suspended or otherwise ineligible to receive federal funds.

 
The Ohio Clinical Trial Collaborative (OCTC)

The Ohio Clinical Trial Collaborative OCTC is developing partnerships with the drug industry to include Biotech and Pharmaceutical industries to perform clinical drug trials phase I-4. The OCTC is a network of Ohio based hospitals led by working groups in areas such as neuro oncology, pediatrics, infectious disease, and neuroscience. The OCTC was launched at the BIO2014 which was attended by 15,000 biotech and pharmaceutical executives in San Diego resulting in numerous leads for potential drug trials.

The OCTC has plans to attend additional biotech and pharmaceuticals shows. The OCTC is looking for additional working groups interested in developing a sell sheet that can then be searched on the World Wide Web and will begin sales and marketing activities to identify opportunities with industry. If there are companies that individuals would like OCTC to target, the group welcomes that feedback.

Review the OCTC working website at: http://ohioclintrials.org.

Contact Joe Peter at 216-702-5314 for more information.

 
New Policy from NIH to Balance Sex in Cell and Animal Studies

NIH announced last week a new policy requiring "a balance of male and female cells and animals in preclinical studies in all future applications." In this week's Nature, Janine Clayton and Francis Collins write, "The over-reliance on male animals and cells in preclinical research obscures key sex differences that could guide clinical studies. And it might be harmful: women experience higher rates of adverse drug reactions than men do. Furthermore, inadequate inclusion of female cells and animals in experiments and inadequate analysis of data by sex may well contribute to the troubling rise of irreproducibility in preclinical biomedical research."

Read more at: http://ow.ly/wSqy6.

 

If you have news or information that you wish to have included in this update, please send it via e-mail to Tracy Wilson-Holden at tracy.wilson-holden@case.edu no later than 5 pm on the Monday of the week that the update is to be distributed. If you know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe to Case Research News, email your request to Tora Williams at tora.williams@case.edu.

Please note: At the time of this transmission, all links functioned. However, Case Research News cannot guarantee that the information will not move or be deleted.